As of May 2012 websites are required by law to gain your consent before applying cookies. We use cookies to improve your browsing experience. Parts of the website may not work as expected without them. By closing this message, you are consenting to our use of cookies. Close Learn more


Changing Market Dynamics in Rheumatoid Arthritis

Join Christina Vasiliou on Thursday 23rd April 2015, as we evaluate Datamonitor Healthcare’s patient-based forecast of key marketed and pipeline brands for the treatment of rheumatoid arthritis.

The lucrative rheumatoid arthritis market, worth in excess of $17bn in the US, Japan, and five major EU markets in 2014, will continue to expand over the next ten years. This webinar will identify and discuss the key treatment trends in rheumatoid arthritis and will examine the dynamics that will contribute to the market’s growth.

* all fields are compulsory

* By registering your personal details, you consent to the use of your information as set out in our privacy policy.
View privacy policy.

Datamonitor Healthcare is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726